Group 1 - The company plans to acquire a 70% stake in Xinxing Huile Electronics Technology Co., Ltd. for no more than 700 million yuan to gain control [1] - The acquisition aims to address competition issues and expand into overseas markets [1] - Huile Electronics specializes in PCB tools, cutting tools, and precision parts, recognized as a national-level "little giant" in the PCB tool segment and a champion enterprise in Henan province [1] Group 2 - The company intends to spend up to 28 million yuan to acquire a 70% stake in WINWIN from Zhang Zhe, spouse of Xu Meihua, to further consolidate control [1] - The acquisition of WINWIN is part of the strategy to resolve industry competition with Huile Electronics [1] - Huile Electronics holds a strong market position and industry influence in the PCB tool sector [1]

长安民生物流(01292)发布公告，现任执行董事万年勇先生(万先生)获委任为董事长，任期自2026年2月 11日起至第六届董事会任期届满之日止。万先生自2026年2月11日起不再担任本公司总经理职务。自 2026年2月11日起至新总经理获委任期间，万先生将代行总经理职责。 董事会建议选举宫永明先生出任本公司非执行董事。建议选举宫永明先生出任本公司非执行董事将以普 通决议案的形式提呈至股东会上由股东批准。 ...

Company Summary - Yidu Tech (02158) announced a share buyback on February 11, repurchasing over 480,000 shares at approximately HKD 6 per share, totaling nearly HKD 3 million, marking the thirteenth consecutive trading day of intensive buybacks, with a cumulative buyback amount exceeding HKD 61 million, demonstrating long-term confidence in the company's value [1][1][1] - Recently, Yidu Tech achieved a business milestone by successfully entering the national Ministry of Industry and Information Technology's "2025 Artificial Intelligence Medical Device Innovation Task" list with a multimodal AI database project for gastrointestinal tumor diagnosis in collaboration with Tongji Hospital of Huazhong University of Science and Technology [1][1][1] Industry Summary - The AI medical sector is at a critical juncture for commercialization, with CITIC Securities reporting that medical AI will accelerate the restructuring of the trillion-dollar pharmaceutical market [1][1][1] - CITIC Securities predicts a fundamental change in the logic of AI medical applications by 2026, driven by clearer and stronger payment capabilities from payers this year, suggesting that 2026 will likely see greater certainty in AI medical commercialization and open up new commercial opportunities [1][1][1] - Key areas to focus on include AI pharmaceuticals, grassroots AI medical applications, medical data circulation and trading, AI pathological diagnosis, AI medical models, and C-end expansion channels, along with related targets [1][1][1]

Group 1 - The company, Fengzhan Holdings (01826), announced that all conditions of the placement agreement have been met, and the placement was completed on February 11, 2026 [1] - A total of 266.4 million shares were placed, representing approximately 16.67% of the company's issued share capital after the placement [1] - The placement shares were sold at a price of HKD 0.153 per share to no fewer than six subscribers [1] Group 2 - Following the completion of the placement, the public float of shares increased from approximately 22.17% to about 35.14%, restoring the public holding to the minimum percentage required by listing rules [1]

医渡科技(02158)发布公告，于2026年2月11日斥资290.62万港元回购48.6万股。 ...

康冠科技（001308）(001308.SZ)发布2026年股票期权激励计划(草案)，拟向激励对象授予股票期权数量 总计2794.016万份，涉及的标的股票种类为A股普通股，约占本激励计划草案公布日公司股本总额的 3.97%。行权价格为21.90元/份。 此次激励计划有效期为自股票期权授予登记完成之日起至激励对象获授的所有股票期权行权或注销完毕 之日止，最长不超过36个月。 ...

粤电力A(000539.SZ)发布公告，2026年2月11日，公司控股子公司广东粤电靖海发电有限公司投资建设 的惠来电厂5、6号机组扩建工程(2×1000MW)项目(以下简称"项目")6号机组通过168小时满负荷试运 行，顺利实现并网投产，正式投入商业运营。至此，项目两台1000MW超超临界二次再热燃煤发电机组 全面建成投产。 ...

Core Viewpoint - Hisense Home Appliances has announced a financial agreement to invest in trust products, indicating a strategic move to enhance its financial management and investment portfolio [1] Group 1: Financial Agreement - Hisense Home Appliances (stock code: 000921) has entered into a financial agreement with Western Trust to subscribe to trust financial products [1] - The total subscription amount for the trust products is set at RMB 1.7 billion [1] - The subscription period is from September 4, 2025, to February 11, 2026 [1]

德康农牧(02419)公布，2026年2月11日耗资约33.75万港元回购4800股股份。 ...

根据供股的接纳结果及配售事项的结果，将予配发及发行的供股股份为2.88亿股供股股份，相当于根据 供股提呈供认购的供股股份总数的100%。 中食民安(08283)发布公告，于2026年2月3日(星期二)下午六时正(即配售截止时间)，所有2.635亿股未获 认购供股股份已根据配售事项按每股股份0.35港元的价格(相等于认购价)成功配售。因此，配售事项下 概无可供分派予不行动股东的净收益。 ...